Lancet Diabetes & Endocrinology r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname The Lancet Diabetes & Endocrinology Volume 7 Issue 8 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Lancet diabetes & endocrinology ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tunon, J, White, H D, Zeiher, A M, Schwartz, G S, Steg, P G, Schwartz, G G, Steg, P G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Nielsen, P K, Davidsen, F, Andersen, D, Jeppesen, J & Videbæk, L 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA Lancet Diabetes and Endocrinology, 7(8), 618-628. ELSEVIER SCIENCE INC
Circulation: Cardiovascular Quality and Outcomes, 12(11). LIPPINCOTT WILLIAMS & WILKINS Circulation : cardiovascular quality and outcomes Circulation-Cardiovascular Quality and Outcomes r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Circulation-cardiovascular Quality And Outcomes, 12(11). Lippincott Williams & Wilkins Szarek, M, Steg, P G, DiCenso, D, Bhatt, D L, Bittner, V A, Budaj, A, Diaz, R, Goodman, S G, Gotcheva, N N, Jukema, J W, Pordy, R, Roe, M T, Sourdille, T, White, H D, Xavier, D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial ', Circulation: Cardiovascular Quality and Outcomes, vol. 12, no. 11, e005858 . https://doi.org/10.1161/CIRCOUTCOMES.119.005858
European heart journal, 32(24), 3147-3197. Oxford University Press Regitz-Zagrosek, Vera; Blomstrom Lundqvist, Carina; Borghi, Claudio; Cifkova, Renata; Ferreira, Rafael; Foidart, Jean-Michel; Gibbs, J Simon R; Gohlke-Baerwolf, Christa; Gorenek, Bulent; Iung, Bernard; Kirby, Mike; Maas, Angela H E M; Morais, Joao; Nihoyannopoulos, Petros; Pieper, Petronella G; Presbitero, Patrizia; Roos-Hesselink, Jolien W; Schaufelberger, Maria; Seeland, Ute; Torracca, Lucia; ... (2011). ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal, 32(24), pp. 3147-97. Oxford: Oxford University Press 10.1093/eurheartj/ehr218
European Heart Journal, 32, 14, pp. 1769-818 European Heart Journal, 32, 1769-818 Reiner, Zeljko; Catapano, Alberico L; De Backer, Guy; Graham, Ian; Taskinen, Marja-Riitta; Wiklund, Olov; Agewall, Stefan; Alegria, Eduardo; Chapman, M John; Durrington, Paul; Erdine, Serap; Halcox, Julian; Hobbs, Richard; Kjekshus, John; Filardi, Pasquale Perrone; Riccardi, Gabriele; Storey, Robert F; Wood, David; ESC Committee for Practice Guidelines (CPG), 2008-2010 and 2010-2012 Committees; Bax, Jeroen; ... (2011). ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal, 32(14), pp. 1769-818. Oxford: Oxford University Press 10.1093/eurheartj/ehr158